GeoVax Labs, Inc. New financials
$0.3520+1.82%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $852.3K | $1.6M | $864.4K | $2.8M | $300.7K | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $852.3K | $1.6M | $864.4K | $2.8M | $300.7K | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — |
| Operating income | -$4.4M | -$5.3M | -$4.4M | -$6.4M | -$5.4M | -$5.4M | -$8.3M | -$5.9M | -$5.1M | -$5.9M | -$7.7M | -$8.6M |
| Net income | -$4.4M | -$5.3M | -$4.4M | -$6.3M | -$5.4M | -$5.4M | -$8.3M | -$5.8M | -$5.1M | -$5.9M | -$7.6M | -$8.4M |
| Net margin | — | — | — | — | −630.0% | −327.3% | −955.9% | −208.5% | −1684.2% | — | — | — |
| Diluted EPS | $-0.97 | $-2.62 | — | $-7.75 | $-8.74 | $-11.20 | $-21.89 | $-22.75 | $-49.75 | $-61.75 | $-87.04 | $-118.75 |
| EBITDA | -$4.4M | -$5.3M | -$4.4M | -$6.4M | -$5.4M | -$5.4M | -$8.3M | -$5.8M | -$5.0M | -$5.9M | -$7.7M | -$8.6M |
| Operating cash flow | -$3.7M | -$3.5M | -$5.0M | -$6.2M | -$4.3M | -$6.0M | -$7.8M | -$9.3M | -$1.9M | -$5.7M | -$10.3M | -$5.1M |
| Free cash flow | -$3.7M | -$3.5M | -$5.0M | -$6.2M | -$4.3M | -$6.0M | -$7.8M | -$9.3M | -$1.9M | -$5.7M | -$10.3M | -$5.1M |
| Diluted shares | 4.6M | 2.0M | — | 0.8M | 0.6M | 0.5M | 0.4M | 0.3M | 0.1M | 0.1M | 0.1M | 0.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.1M | $1.3M | $3.1M | $5.0M | $3.1M | $7.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $4.6M | $3.0M | $6.3M | $6.7M | $5.4M | $10.8M |
| Total liabilities | $2.9M | $2.5M | $2.5M | $1.8M | $2.5M | $2.9M |
| Shareholders' equity | $1.8M | $493.8K | $3.8M | $4.9M | $2.8M | $7.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology